79 related articles for article (PubMed ID: 8572578)
1. Prognostic relevance of Ki-67 antigen and c-myc oncoprotein in malignant fibrous histocytoma.
Brinck U; Stachura J; Kellner S; Schauer A
Anticancer Res; 1995; 15(5B):1915-9. PubMed ID: 8572578
[TBL] [Abstract][Full Text] [Related]
2. P-53 positivity and high proliferative index: factors of bad prognosis in malignant fibrous histiocytomas.
Brinck U; Stachura J; Rudzki Z; Kellner S; Hoefer K; Schauer A
In Vivo; 1995; 9(5):475-8. PubMed ID: 8900926
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
4. c-myc protein and Ki-67 antigen immunodetection in patients with uterine cervix neoplasia: correlation of microcytophotometric analysis and histological data.
Devictor B; Bonnier P; Piana L; Andrac L; Lavaut MN; Allasia C; Charpin C
Gynecol Oncol; 1993 Jun; 49(3):284-90. PubMed ID: 8390959
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of histologic grading, the cell cycle-associated antigen Ki-S1 and cell cycle regulators in malignant fibrous histiocytomas: a multivariate analysis.
Brinck U; Cordon-Cardo C; Korabiowska M; Kellner S; Trybus-Galuszka H; Stachura J; Parwaresch MR; Schauer A
Verh Dtsch Ges Pathol; 1998; 82():232-8. PubMed ID: 10095440
[TBL] [Abstract][Full Text] [Related]
6. Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis.
King LA; Okagaki T; Gallup DG; Twiggs LB; Messing MJ; Carson LF
Gynecol Oncol; 1996 May; 61(2):227-32. PubMed ID: 8626138
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas.
Hagel C; Krog B; Laas R; Stavrou DK
J Exp Clin Cancer Res; 1999 Sep; 18(3):305-9. PubMed ID: 10606174
[TBL] [Abstract][Full Text] [Related]
9. [Positive expression of c-myc and p53 products in two cases of pulmonary sclerosing hemangioma].
Chiba W; Sawai S; Yasuda Y; Wazawa H; Matsubara Y; Ikeda S
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33(12):1348-54. PubMed ID: 8821986
[TBL] [Abstract][Full Text] [Related]
10. Relevance of ploidy related parameters for prognosis in malignant fibrous histiocytomas.
Brinck U; Korabiowska M; Buschmann N; Stachura J; Ruschenburg I; Cordon-Cardo C; Schauer A
Anticancer Res; 1999; 19(6B):5211-6. PubMed ID: 10697537
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 and grading of malignant fibrous histiocytomas.
Zehr RJ; Bauer TW; Marks KE; Weltevreden A
Chir Organi Mov; 1990; 75(1 Suppl):123-5. PubMed ID: 2174325
[No Abstract] [Full Text] [Related]
12. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific?
Choong PF; Akerman M; Willén H; Andersson C; Gustafson P; Alvegård T; Rydholm A
APMIS; 1995 Nov; 103(11):797-805. PubMed ID: 8546844
[TBL] [Abstract][Full Text] [Related]
13. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
Selim AG; El-Ayat G; Wells CA
Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical status of p53, mdm2 and Ki-67 in malignant fibrous histiocytoma.
Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
Pol J Pathol; 1998; 49(1):15-21. PubMed ID: 9640970
[TBL] [Abstract][Full Text] [Related]
16. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 and grading of malignant fibrous histiocytomas.
Zehr RJ; Bauer TW; Marks KE; Weltevreden A
Cancer; 1990 Nov; 66(9):1984-90. PubMed ID: 2171753
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma.
Ricaniadis N; Kataki A; Agnantis N; Androulakis G; Karakousis CP
Eur J Surg Oncol; 2001 Feb; 27(1):88-93. PubMed ID: 11237497
[TBL] [Abstract][Full Text] [Related]
19. The pattern of Ki-67 and bcl-2 expression in lymphoid malignancies.
Wang PL; Peh SC
Malays J Pathol; 1997 Jun; 19(1):59-64. PubMed ID: 10879243
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma.
Ross DA; Wilson GD
Br J Surg; 1998 Jan; 85(1):46-51. PubMed ID: 9462382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
